ACUPHARMA ApS: Financial statements 2019
CVR: 10072956
Source: annual report 2019, Danish Business Authority
01/10/2018 – 30/09/2019
ACUPHARMA ApS (CVR 10072956) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 1,684,289 and a net result of DKK 32,839 compared with DKK 5,216 the year before. That is a decrease of 2.3% compared with the year before. Equity in the 2019 report amounted to DKK 386,805. The solvency ratio was 11.7%. The company had 4 employees in the financial year.
- Gross Profit
- DKK 1,684,289
- Profit/Loss
- DKK 32,839
- Equity
- DKK 386,805
- Total Assets
- DKK 3,292,250
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 1.7 mio. | 33 t. | 387 t. | 4 |
| 2018 | - | 1.7 mio. | 5 t. | 154 t. | - |
| 2017 | - | 1.5 mio. | 80 t. | 149 t. | - |
| 2016 | - | 1.1 mio. | 105 | 68 t. | - |
| 2015 | - | 322 t. | -360 t. | 68 t. | - |
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
ACUPHARMA ApS has published its annual report for 2018. Gross profit came to DKK 1,724,257, and the net result was DKK 5,216.
About ACUPHARMA ApS
ACUPHARMA ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2001. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Christina Uekermann Skive and Jeanne Helsted. The company is owned by SKIVE & HELSTED A/S. The company has 5 employees (2018). In 2025, the company reported a gross profit of DKK 1,150,834 and a net result of DKK 287,572 compared with DKK -258,766 the year before. Equity in the 2025 report amounted to DKK -109,301.